vs
帕可Bio（PACB）与Quanterix Corp（QTRX）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是Quanterix Corp的1.0倍（$44.6M vs $43.9M）。Quanterix Corp净利率更高（-52.7% vs -90.4%，领先37.7%）。Quanterix Corp同比增速更快（24.7% vs 13.8%）。Quanterix Corp自由现金流更多（$-16.5M vs $-19.9M）。过去两年Quanterix Corp的营收复合增速更高（16.9% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
Quanterix Corp是一家生命科学企业，研发、生产和销售超高灵敏度单分子检测诊断平台、试剂及检测服务，覆盖肿瘤、神经退行性疾病、传染病等领域，为全球科研机构、生物制药企业及临床实验室提供研究、药物开发及临床诊断相关支持。
PACB vs QTRX — 直观对比
营收规模更大
PACB
是对方的1.0倍
$43.9M
营收增速更快
QTRX
高出10.9%
13.8%
净利率更高
QTRX
高出37.7%
-90.4%
自由现金流更多
QTRX
多$3.4M
$-19.9M
两年增速更快
QTRX
近两年复合增速
7.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $43.9M |
| 净利润 | $-40.4M | $-23.1M |
| 毛利率 | 37.1% | 45.7% |
| 营业利润率 | -92.3% | -56.4% |
| 净利率 | -90.4% | -52.7% |
| 营收同比 | 13.8% | 24.7% |
| 净利润同比 | -1802.7% | -98.8% |
| 每股收益（稀释后） | $-0.11 | $-0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBQTRX
| Q4 25 | $44.6M | $43.9M | ||
| Q3 25 | $38.4M | $40.2M | ||
| Q2 25 | $39.8M | $24.5M | ||
| Q1 25 | $37.2M | $30.3M | ||
| Q4 24 | $39.2M | $35.2M | ||
| Q3 24 | $40.0M | $35.8M | ||
| Q2 24 | $36.0M | $34.4M | ||
| Q1 24 | $38.8M | $32.1M |
净利润PACBQTRX
| Q4 25 | $-40.4M | $-23.1M | ||
| Q3 25 | $-38.0M | $-33.5M | ||
| Q2 25 | $-41.9M | $-30.0M | ||
| Q1 25 | $-426.1M | $-20.5M | ||
| Q4 24 | $2.4M | $-11.6M | ||
| Q3 24 | $-60.7M | $-8.4M | ||
| Q2 24 | $-173.3M | $-7.4M | ||
| Q1 24 | $-78.2M | $-11.2M |
毛利率PACBQTRX
| Q4 25 | 37.1% | 45.7% | ||
| Q3 25 | 41.4% | 42.8% | ||
| Q2 25 | 36.9% | 46.2% | ||
| Q1 25 | -3.7% | 54.1% | ||
| Q4 24 | 25.6% | 63.0% | ||
| Q3 24 | 25.0% | 56.3% | ||
| Q2 24 | 16.5% | 64.7% | ||
| Q1 24 | 29.1% | 57.8% |
营业利润率PACBQTRX
| Q4 25 | -92.3% | -56.4% | ||
| Q3 25 | -101.1% | -92.8% | ||
| Q2 25 | -112.8% | -151.6% | ||
| Q1 25 | -1154.5% | -86.9% | ||
| Q4 24 | -390.1% | -42.0% | ||
| Q3 24 | -160.3% | -32.8% | ||
| Q2 24 | -488.3% | -31.8% | ||
| Q1 24 | -209.6% | -47.3% |
净利率PACBQTRX
| Q4 25 | -90.4% | -52.7% | ||
| Q3 25 | -98.9% | -83.3% | ||
| Q2 25 | -105.4% | -122.6% | ||
| Q1 25 | -1146.8% | -67.6% | ||
| Q4 24 | 6.0% | -33.1% | ||
| Q3 24 | -151.9% | -23.3% | ||
| Q2 24 | -481.3% | -21.5% | ||
| Q1 24 | -201.4% | -34.8% |
每股收益（稀释后）PACBQTRX
| Q4 25 | $-0.11 | $-0.48 | ||
| Q3 25 | $-0.13 | $-0.73 | ||
| Q2 25 | $-0.14 | $-0.77 | ||
| Q1 25 | $-1.44 | $-0.53 | ||
| Q4 24 | $-0.44 | $-0.30 | ||
| Q3 24 | $-0.22 | $-0.22 | ||
| Q2 24 | $-0.64 | $-0.19 | ||
| Q1 24 | $-0.29 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $29.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $295.7M |
| 总资产 | $784.1M | $418.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PACBQTRX
| Q4 25 | $279.5M | $29.8M | ||
| Q3 25 | $298.7M | $38.3M | ||
| Q2 25 | $314.7M | $132.9M | ||
| Q1 25 | $343.1M | $76.5M | ||
| Q4 24 | $389.9M | $56.7M | ||
| Q3 24 | $471.1M | $29.3M | ||
| Q2 24 | $509.8M | $47.0M | ||
| Q1 24 | $561.9M | $45.3M |
股东权益PACBQTRX
| Q4 25 | $5.3M | $295.7M | ||
| Q3 25 | $36.1M | $314.5M | ||
| Q2 25 | $61.5M | $292.5M | ||
| Q1 25 | $91.6M | $316.4M | ||
| Q4 24 | $506.6M | $330.0M | ||
| Q3 24 | $453.1M | $338.9M | ||
| Q2 24 | $492.7M | $340.8M | ||
| Q1 24 | $649.0M | $343.4M |
总资产PACBQTRX
| Q4 25 | $784.1M | $418.8M | ||
| Q3 25 | $803.2M | $444.1M | ||
| Q2 25 | $825.5M | $375.6M | ||
| Q1 25 | $860.8M | $396.5M | ||
| Q4 24 | $1.3B | $406.5M | ||
| Q3 24 | $1.5B | $411.0M | ||
| Q2 24 | $1.5B | $415.9M | ||
| Q1 24 | $1.7B | $414.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $-16.4M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $-16.5M |
| 自由现金流率自由现金流/营收 | -44.6% | -37.7% |
| 资本支出强度资本支出/营收 | 1.9% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $-80.0M |
8季度趋势，按日历期对齐
经营现金流PACBQTRX
| Q4 25 | $-19.1M | $-16.4M | ||
| Q3 25 | $-18.7M | $-41.2M | ||
| Q2 25 | $-29.4M | $-5.7M | ||
| Q1 25 | $-44.1M | $-13.9M | ||
| Q4 24 | $-30.6M | $-4.3M | ||
| Q3 24 | $-45.5M | $-5.7M | ||
| Q2 24 | $-54.3M | $-5.0M | ||
| Q1 24 | $-75.7M | $-20.2M |
自由现金流PACBQTRX
| Q4 25 | $-19.9M | $-16.5M | ||
| Q3 25 | $-18.8M | $-41.9M | ||
| Q2 25 | $-29.9M | $-6.4M | ||
| Q1 25 | $-45.4M | $-15.1M | ||
| Q4 24 | $-32.3M | $-4.7M | ||
| Q3 24 | $-46.3M | $-6.6M | ||
| Q2 24 | $-55.7M | $-6.5M | ||
| Q1 24 | $-79.6M | $-20.7M |
自由现金流率PACBQTRX
| Q4 25 | -44.6% | -37.7% | ||
| Q3 25 | -48.9% | -104.2% | ||
| Q2 25 | -75.3% | -26.3% | ||
| Q1 25 | -122.3% | -49.9% | ||
| Q4 24 | -82.3% | -13.4% | ||
| Q3 24 | -115.7% | -18.4% | ||
| Q2 24 | -154.8% | -19.1% | ||
| Q1 24 | -205.0% | -64.5% |
资本支出强度PACBQTRX
| Q4 25 | 1.9% | 0.2% | ||
| Q3 25 | 0.2% | 1.7% | ||
| Q2 25 | 1.4% | 3.2% | ||
| Q1 25 | 3.7% | 4.1% | ||
| Q4 24 | 4.1% | 1.2% | ||
| Q3 24 | 2.0% | 2.4% | ||
| Q2 24 | 4.1% | 4.7% | ||
| Q1 24 | 10.0% | 1.6% |
现金转化率PACBQTRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
QTRX
| Products | $29.2M | 67% |
| Consumable And Other Products | $12.7M | 29% |
| Service Type Warranties | $1.7M | 4% |
